Published on 23/12/2025
Techniques for Simplifying Informed Consent Language in Clinical Research
Why Simplification of Consent Language Matters
Informed consent documents are often written at a high reading level, filled with legal jargon and medical terminology. For participants, especially those with low literacy or from non-medical backgrounds, this creates barriers to understanding. According to ICH-GCP, informed consent must ensure that participants fully comprehend the trial’s purpose, risks, and benefits. Thus, simplifying consent language is not only an ethical requirement but also a regulatory mandate.
Readability studies show that many consent forms are written at a college reading level, while health literacy experts recommend a 6th–8th grade reading level. This mismatch can undermine participant autonomy and even risk non-compliance during audits. Ethics committees increasingly emphasize readability and participant comprehension in their reviews.
Core Principles of Simplification
- ➤ Plain Language: Replace medical jargon with everyday words. For example, use “heart attack” instead of “myocardial infarction.”
- ➤ Short Sentences: Limit sentences to 15–20 words to improve readability.
- ➤ Active Voice: Use “You will take the medicine daily” instead of “The medicine is to be taken daily.”
- ➤ Consistent Terminology: Avoid switching between synonyms for the same concept (e.g., drug, medication, treatment).
- ➤ Visual Aids:
Applying these techniques increases participant confidence and reduces dropout rates during clinical trials.
Using Readability Metrics
Several readability tools can help assess the language level of consent forms. Commonly used indices include:
| Metric | Target Score | Compliance Indicator |
|---|---|---|
| Flesch Reading Ease | ≥ 60 | ✅ Easy to read |
| Flesch-Kincaid Grade Level | 6–8 | ✅ Participant-friendly |
| SMOG Index | ≤ 8 | ✅ Acceptable for laypersons |
Regulators and IRBs may request readability assessments as part of submission packages to ensure participants are not disadvantaged by complex language.
Practical Techniques for Rewriting
Consider the following techniques when rewriting consent forms:
- ✅ Break complex procedures into step-by-step explanations
- ✅ Replace statistics with plain explanations (“1 out of 10 people may feel tired”)
- ✅ Use bullet points and headings to separate information
- ✅ Highlight key messages (risks, rights, benefits)
Example before-and-after comparison:
| Before | After |
|---|---|
| The investigational medicinal product may induce gastrointestinal disturbances of varying severity. | You may experience stomach problems such as nausea or diarrhea. |
| Participation in this clinical investigation is entirely voluntary and subject to withdrawal without prejudice. | You can choose to leave the study at any time without affecting your medical care. |
Case Study: Improving Consent in Oncology Trials
In a multicenter oncology trial, initial consent documents scored at a 14th-grade level. After applying simplification techniques, the documents were reduced to an 8th-grade level. Feedback from participants indicated improved comprehension, and the ethics committee approved the revised form without requests for further clarification.
Global Considerations in Simplification
International trials face challenges in ensuring readability across diverse cultures and languages:
- ➤ Translate into local languages with cultural adaptation
- ➤ Ensure terms align with literacy levels in the target population
- ➤ Pilot test forms with small groups for comprehension
- ➤ Address regional regulatory expectations (e.g., EMA emphasizes lay summaries)
Resources such as the ISRCTN Registry provide examples of plain-language summaries that align with best practices for simplifying complex trial information.
Conclusion
Simplifying informed consent language is a crucial step in enhancing transparency, ensuring ethical compliance, and empowering participants. By applying readability metrics, rewriting complex terms into plain language, and involving participants in pre-testing, sponsors and investigators can achieve both regulatory compliance and participant trust. Ultimately, informed consent should be a bridge to understanding—not a barrier.